Rainer Fietkau

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 36

Top Topics

Locally Advanced

Early Breast Cancer

Extracellular Matrix

Top Venues

International journal of molecular sciences

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Nina Klieber, Laura S Hildebrand, Eva Faulhaber, Julia Symank, Nicole Häck, Annamaria Härtl, Rainer Fietkau, Luitpold Valentin Distel
Different Impacts of DNA-PK and mTOR Kinase Inhibitors in Combination with Ionizing Radiation on HNSCC and Normal Tissue Cells. Cells 13 (4) (2024)
Jacob Mentzel, Laura S Hildebrand, Lukas Kuhlmann, Rainer Fietkau, Luitpold Valentin Distel
Effective Radiosensitization of HNSCC Cell Lines by DNA-PKcs Inhibitor AZD7648 and PARP Inhibitors Talazoparib and Niraparib. International journal of molecular sciences 25 (11) (2024)
Jacob Mentzel, Laura S Hildebrand, Lukas Kuhlmann, Rainer Fietkau, Luitpold Valentin Distel
Effective Radiosensitization of HNSCC Cell Lines by DNA-PKcs Inhibitor AZD7648 and PARP Inhibitors Talazoparib and Niraparib. International journal of molecular sciences 25 (11) (2024)
Nina Klieber, Laura S Hildebrand, Eva Faulhaber, Julia Symank, Nicole Häck, Annamaria Härtl, Rainer Fietkau, Luitpold Valentin Distel
Different Impacts of DNA-PK and mTOR Kinase Inhibitors in Combination with Ionizing Radiation on HNSCC and Normal Tissue Cells. Cells 13 (4) (2024)
Nina Klieber, Laura S Hildebrand, Eva Faulhaber, Julia Symank, Nicole Häck, Annamaria Härtl, Rainer Fietkau, Luitpold Valentin Distel
Different Impacts of DNA-PK and mTOR Kinase Inhibitors in Combination with Ionizing Radiation on HNSCC and Normal Tissue Cells. Cells 13 (4) (2024)
Nina Klieber, Laura S Hildebrand, Eva Faulhaber, Julia Symank, Nicole Häck, Annamaria Härtl, Rainer Fietkau, Luitpold Valentin Distel
Different Impacts of DNA-PK and mTOR Kinase Inhibitors in Combination with Ionizing Radiation on HNSCC and Normal Tissue Cells. Cells 13 (4) (2024)
Johanna Berfelde, Laura S Hildebrand, Lukas Kuhlmann, Rainer Fietkau, Luitpold Valentin Distel
FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1. International journal of molecular sciences 25 (4) (2024)
Johanna Berfelde, Laura S Hildebrand, Lukas Kuhlmann, Rainer Fietkau, Luitpold Valentin Distel
FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1. International journal of molecular sciences 25 (4) (2024)
Jacob Mentzel, Laura S Hildebrand, Lukas Kuhlmann, Rainer Fietkau, Luitpold Valentin Distel
Effective Radiosensitization of HNSCC Cell Lines by DNA-PKcs Inhibitor AZD7648 and PARP Inhibitors Talazoparib and Niraparib. International journal of molecular sciences 25 (11) (2024)
Nina Klieber, Laura S Hildebrand, Eva Faulhaber, Julia Symank, Nicole Häck, Annamaria Härtl, Rainer Fietkau, Luitpold Valentin Distel
Different Impacts of DNA-PK and mTOR Kinase Inhibitors in Combination with Ionizing Radiation on HNSCC and Normal Tissue Cells. Cells 13 (4) (2024)
Johanna Berfelde, Laura S Hildebrand, Lukas Kuhlmann, Rainer Fietkau, Luitpold Valentin Distel
FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1. International journal of molecular sciences 25 (4) (2024)
Johanna Berfelde, Laura S Hildebrand, Lukas Kuhlmann, Rainer Fietkau, Luitpold Valentin Distel
FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1. International journal of molecular sciences 25 (4) (2024)
Daniel Blasko, Claudia Schweizer, Tim Fitz, Christoph Schröter, Christopher Sörgel, Annett Kallies, Rainer Fietkau, Luitpold Valentin Distel
Impact of COVID-19 on Quality of Life in Long-Term Advanced Rectal Cancer Survivors. Healthcare (Basel, Switzerland) 11 (14) (2023)
Ilka Scheer, Ina Becker, Charlotte Schmitter, Sabine Semrau, Rainer Fietkau, Udo S Gaipl, Benjamin Frey, Anna-Jasmina Donaubauer
Prospective Evaluation of CD45RA+/CCR7- Effector Memory T (T EMRA ) Cell Subsets in Patients with Primary and Secondary Brain Tumors during Radiotherapy of the Brain within the Scope of the Prospective Glio-CMV-01 Clinical Trial. Cells 12 (4) (2023)
Ilka Scheer, Ina Becker, Charlotte Schmitter, Sabine Semrau, Rainer Fietkau, Udo S Gaipl, Benjamin Frey, Anna-Jasmina Donaubauer
Prospective Evaluation of CD45RA+/CCR7- Effector Memory T (T EMRA ) Cell Subsets in Patients with Primary and Secondary Brain Tumors during Radiotherapy of the Brain within the Scope of the Prospective Glio-CMV-01 Clinical Trial. Cells 12 (4) (2023)
Tim-Oliver Sauer, Wilhelm Stillkrieg, Oliver J Ott, Rainer Fietkau, Christoph Bert
Plan robustness analysis for threshold determination of SGRT-based intrafraction motion control in 3DCRT breast cancer radiation therapy. Radiation oncology (London, England) 18 (1) (2023)
Ilka Scheer, Ina Becker, Charlotte Schmitter, Sabine Semrau, Rainer Fietkau, Udo S Gaipl, Benjamin Frey, Anna-Jasmina Donaubauer
Prospective Evaluation of CD45RA+/CCR7- Effector Memory T (T EMRA ) Cell Subsets in Patients with Primary and Secondary Brain Tumors during Radiotherapy of the Brain within the Scope of the Prospective Glio-CMV-01 Clinical Trial. Cells 12 (4) (2023)
Luzie Helene Unseld, Laura S Hildebrand, Florian Putz, Maike Büttner-Herold, Christoph Daniel, Rainer Fietkau, Luitpold Valentin Distel
Non-Professional Phagocytosis Increases in Melanoma Cells and Tissues with Increasing E-Cadherin Expression. Current oncology (Toronto, Ont.) 30 (8) (2023)
Mareike F Bauer, Laura S Hildebrand, Marie-Charlotte Rosahl, Ramona Erber, Sören Schnellhardt, Maike Büttner-Herold, Florian Putz, Oliver J Ott, Carolin C Hack, Rainer Fietkau, Luitpold Valentin Distel
Cell-In-Cell Structures in Early Breast Cancer Are Prognostically Valuable. Cells 12 (1) (2022)
Mareike F Bauer, Laura S Hildebrand, Marie-Charlotte Rosahl, Ramona Erber, Sören Schnellhardt, Maike Büttner-Herold, Florian Putz, Oliver J Ott, Carolin C Hack, Rainer Fietkau, Luitpold Valentin Distel
Cell-In-Cell Structures in Early Breast Cancer Are Prognostically Valuable. Cells 12 (1) (2022)
Johannes G Dinkel, Godehard Lahmer, Angelika Barbara Mennecke, Stefan W Hock, Tanja Richter-Schmidinger, Rainer Fietkau, Luitpold Valentin Distel, Florian Putz, Arnd Dörfler, Manuel Alexander Schmidt
Effects of Hippocampal Sparing Radiotherapy on Brain Microstructure-A Diffusion Tensor Imaging Analysis. Brain sciences 12 (7) (2022)
Mareike F Bauer, Laura S Hildebrand, Marie-Charlotte Rosahl, Ramona Erber, Sören Schnellhardt, Maike Büttner-Herold, Florian Putz, Oliver J Ott, Carolin C Hack, Rainer Fietkau, Luitpold Valentin Distel
Cell-In-Cell Structures in Early Breast Cancer Are Prognostically Valuable. Cells 12 (1) (2022)
Tim-Oliver Sauer, Oliver J Ott, Godehard Lahmer, Rainer Fietkau, Christoph Bert
Prerequisites for the clinical implementation of a markerless SGRT-only workflow for the treatment of breast cancer patients. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2022)
Lisa Deloch, Stephanie Hehlgans, Michael Rückert, Andreas Maier, Annika Hinrichs, Ann-Sophie Flohr, Denise Eckert, Thomas Weissmann, Michaela Seeling, Falk Nimmerjahn, Rainer Fietkau, Franz Rödel, Claudia Fournier, Benjamin Frey, Udo S Gaipl
Radon Improves Clinical Response in an Animal Model of Rheumatoid Arthritis Accompanied by Increased Numbers of Peripheral Blood B Cells and Interleukin-5 Concentration. Cells 11 (4) (2022)
Sarina Katrin Müller, Marlen Haderlein, Sebastian Lettmaier, Abbas Agaimy, Florian Haller, Markus Hecht, Rainer Fietkau, Heinrich Iro, Konstantinos Mantsopoulos
Targeted Therapy, Chemotherapy, Immunotherapy and Novel Treatment Options for Different Subtypes of Salivary Gland Cancer. Journal of clinical medicine 11 (3) (2022)
Mareike F Bauer, Laura S Hildebrand, Marie-Charlotte Rosahl, Ramona Erber, Sören Schnellhardt, Maike Büttner-Herold, Florian Putz, Oliver J Ott, Carolin C Hack, Rainer Fietkau, Luitpold Valentin Distel
Cell-In-Cell Structures in Early Breast Cancer Are Prognostically Valuable. Cells 12 (1) (2022)
Michael Beck, Sabine Semrau, Marlen Haderlein, Antoniu-Oreste Gostian, Julius Hartwich, Sarina Katrin Müller, Annett Kallies, Carol-Immanuel Geppert, Miriam Schonath, Florian Putz, Udo S Gaipl, Benjamin Frey, Marc Saake, Heinrich Iro, Michael Uder, Arndt Hartmann, Torsten Kuwert, Rainer Fietkau, Markus Eckstein, Markus Hecht
Differences and Similarities in the Pattern of Early Metabolic and Morphologic Response after Induction Chemo-Immunotherapy versus Induction Chemotherapy Alone in Locally Advanced Squamous Cell Head and Neck Cancer. Cancers 14 (19) (2022)
Ziad Maksoud, Manuel Alexander Schmidt, Yixing Huang, Sandra Rutzner, Sina Mansoorian, Thomas Weissmann, Christoph Bert, Luitpold Valentin Distel, Sabine Semrau, Sebastian Lettmaier, Ilker Eyüpoglu, Rainer Fietkau, Florian Putz
Transient Enlargement in Meningiomas Treated with Stereotactic Radiotherapy. Cancers 14 (6) (2022)
Oliver J Ott, Wilhelm Stillkrieg, Ulrike Lambrecht, Tim-Oliver Sauer, Claudia Schweizer, Allison Lamrani, Vratislav Strnad, Carolin C Hack, Matthias W Beckmann, Michael Uder, Rainer Fietkau, Luitpold Valentin Distel
External Beam Accelerated Partial Breast Irradiation in Early Breast Cancer and the Risk for Radiogenic Pneumonitis. Cancers 14 (14) (2022)
Felix Eisenhut, Tobias Engelhorn, Soheil Arinrad, Sebastian Brandner, Roland Coras, Florian Putz, Rainer Fietkau, Arnd Doerfler, Manuel Alexander Schmidt
A Comparison of Single- and Multiparametric MRI Models for Differentiation of Recurrent Glioblastoma from Treatment-Related Change. Diagnostics (Basel, Switzerland) 11 (12) (2021)
Maike Jörling, Sandra Rutzner, Markus Hecht, Rainer Fietkau, Luitpold Valentin Distel
Deterioration of Health-Related Quality of Life Scores under Treatment Predicts Longer Survival. BioMed research international 2020 (2020)
Lisa Deloch, Jana Fuchs, Michael Rückert, Rainer Fietkau, Benjamin Frey, Udo S Gaipl
Low-Dose Irradiation Differentially Impacts Macrophage Phenotype in Dependence of Fibroblast-Like Synoviocytes and Radiation Dose. Journal of immunology research 2019 (2019)
Ricarda Merten, Oliver J Ott, Marlen Haderlein, Simone Bertz, Arndt Hartmann, Bernd Wullich, Bastian Keck, Reinhard Kühn, Claus Michael Rödel, Christian Weiss, Christine M Gall, Wolfgang Uter, Rainer Fietkau
Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2). The oncologist 24 (12) (2019)
Max J Weiling, Wencke Losensky, Katharina Wächter, Teresa Schilling, Fabian Frank, Matthias Haas, Rainer Fietkau, Luitpold Valentin Distel, Stephanie Weiss
Older Patients Are Less Affected by Radiochemotherapeutic Treatment than Younger. BioMed research international 2018 (2018)
Roland Wunderlich, Paul Friedrich Rühle, Lisa Deloch, Franz Rödel, Rainer Fietkau, Udo S Gaipl, Benjamin Frey
Ionizing radiation reduces the capacity of activated macrophages to induce T-cell proliferation, but does not trigger dendritic cell-mediated non-targeted effects. International journal of radiation biology 95 (1) (2018)
Sebastian Winkler, Philipp Hoppe, Marlen Haderlein, Markus Hecht, Rainer Fietkau, Luitpold Valentin Distel
Ex Vivo Apoptosis in CD8+ Lymphocytes Predicts Rectal Cancer Patient Outcome. Gastroenterology research and practice 2016 (2016)
Jens Wölfelschneider, Tobias Brandt, Sebastian Lettmaier, Rainer Fietkau, Christoph Bert
Quantification of an external motion surrogate for quality assurance in lung cancer radiation therapy. BioMed research international 2014 (2014)